HLA-antigens in systemic lupus erythematosus (SLE)

Area of Science:

• Immunogenetics
• Rheumatology
• Clinical Immunology

Background:

• Systemic Lupus Erythematosus (SLE) is a complex autoimmune disease with a known genetic component.
• Histocompatibility antigens, particularly Human Leukocyte Antigens (HLAs), play a crucial role in immune regulation and are often associated with autoimmune conditions.

Purpose of the Study:

• To investigate the association between specific histocompatibility antigens and the presence of Systemic Lupus Erythematosus (SLE).
• To determine if HLA-B8 is a risk factor for developing SLE.

Main Methods:

• Histocompatibility antigen typing was performed on 27 patients diagnosed with SLE.
• A control group of 283 healthy blood donors was included for comparison.
• Statistical analysis was used to compare antigen frequencies between patients and controls.

Main Results:

• A significantly higher frequency of HLA-B8 was observed in SLE patients (59.3%) compared to the control group (20.5%).
• The relative risk for developing SLE associated with HLA-B8 was calculated to be 5.64.
• No significant correlation was found between HLA-B8 and disease manifestations, immunopathology, age of onset, or prognosis.

Conclusions:

• The Human Leukocyte Antigen B8 (HLA-B8) is significantly associated with Systemic Lupus Erythematosus (SLE).
• HLA-B8 may represent a genetic susceptibility factor for SLE.
• Further research is warranted to understand the specific mechanisms linking HLA-B8 to SLE pathogenesis.